secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001213900-25-100019
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies adjourns 2025 annual meeting to Oct 21; posts investor presentation
--------------------------------------------------------------------------------

- Annual meeting adjourned on Oct 14; reconvenes virtually Oct 21 at 10:00 a.m. ET to allow more proxy solicitation time.
- Issuance Proposal, Charter Amendment, and Auditor Ratification already received requisite votes per preliminary tabulation.
- Company posted an investor presentation to ir.ostherapies.com on Oct 17; expect to use it in investor meetings.
- Stockholders who haven't voted can vote until Oct 20 at 11:59 p.m. ET or at reconvened meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025100019/0001213900-25-100019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025100019/ea0261257-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-100019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer